Analystreport

Castle Biosciences (NASDAQ:CSTL) had its "buy" rating reaffirmed by analysts at BTIG Research.

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report